Sign In
Buy ATNM
$1.11
-0.0500 (-4.31%)
At Close: Jun 04, 2026
NEW YORK, June 15, 2021 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) ("Actinium" or the "Company") today highlighted data from its pivotal Phase 3 SIERRA trial for Iomab-B i
NEW YORK, June 15, 2021 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) ("Actinium") today highlighted safety data from its ongoing pivotal Phase 3 SIERRA trial of Iomab-B in p
Surging Earnings Estimates Signal Good News for Actinium (ATNM)
09:46am, Wednesday, 09'th Jun 2021
Actinium (ATNM) is seeing positive earnings estimate revisions, suggesting that it could be a solid choice for investors.
Actinium Activates Radiation Inside the Body for Target Conditioning of Cancer Cells
10:00am, Thursday, 03'rd Jun 2021
Actinium Pharmaceuticals Inc. (NYSE: ATNM), a clinical-stage biopharmaceutical company, is developing antibody radiation-conjugates (ARCs) to combine the targeting ability of antibodies with the cell-
Actinium Announces Several Presentations from the Phase 3 SIERRA Study of Iomab-B at the SNMMI 2021 Virtual Annual Meeting
09:06am, Thursday, 03'rd Jun 2021
NEW YORK, June 3, 2021 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) ("Actinium" or the "Company") today announced that three abstracts highlighting data and findings from th
7 Reddit Penny Stocks Promising to Cure Cancer
10:25am, Friday, 14'th May 2021
These seven risky Reddit penny stocks are in the biotech space and the business of developing cancer therapies and treatments. The post 7 Reddit Penny Stocks Promising to Cure Cancer appeared first on
Actinium to Participate in the Cell & Gene Meeting on the Mediterranean
06:11pm, Wednesday, 31'st Mar 2021
NEW YORK, March 31, 2021 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) ("Actinium" or the "Company") today announced that it will be participating in the Cell & Gene Meeting o
Actinium Announces Completion of Enrollment of Second Dose Cohort in Actimab-A Venetoclax Combination Trial for Patients with R/R AML
09:00am, Thursday, 25'th Mar 2021
NEW YORK, March 25, 2021 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) ("Actinium" or the "Company") today announced that initial patient enrollment in the second dose cohort
Actinium Announces Initiation of Patient Enrollment in Iomab-ACT Trial for Targeted Conditioning Prior to CD19 CAR T-Cell Therapy
07:30am, Wednesday, 24'th Mar 2021
NEW YORK, March 24, 2021 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) ("Actinium" or the "Company") today announced that its collaborator, Memorial Sloan Kettering Cancer Ce
Actinium to Highlight Expansion of Targeted Conditioning Portfolio at AACR with Next-Generation Actinium-225-Based CD45 Targeting ARC
07:00am, Thursday, 11'th Mar 2021
NEW YORK, March 11, 2021 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) ("Actinium" or the "Company") today announced that preclinical feasibility data supporting an Actinium-
Actinium Announces Successful Pre-Planned Ad Hoc Interim Analysis of Phase 3 SIERRA trial
08:30am, Tuesday, 29'th Dec 2020
NEW YORK, Dec. 29, 2020 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) ("Actinium" or the "Company") today announced that the independent Data Monitoring Committee (DMC) has comp
Actinium Pharmaceuticals (ATNM) Outpaces Stock Market Gains: What You Should Know
06:49pm, Wednesday, 23'rd Dec 2020
Actinium Pharmaceuticals (ATNM) closed the most recent trading day at $11.22, moving +0.9% from the previous trading session.
Actinium Pharmaceuticals (ATNM) Stock Sinks As Market Gains: What You Should Know
06:48pm, Thursday, 17'th Dec 2020
Actinium Pharmaceuticals (ATNM) closed the most recent trading day at $11.40, moving -1.04% from the previous trading session.
Actinium Pharmaceuticals: Our Bullish View Is Intact On Promising Early Stage Results
02:14pm, Friday, 04'th Dec 2020
Additional early stage results continue to be promising. The cash balance is adequate.
Actinium Pharmaceuticals (ATNM) Dips More Than Broader Markets: What You Should Know
05:45pm, Friday, 20'th Nov 2020
In the latest trading session, Actinium Pharmaceuticals (ATNM) closed at $11.16, marking a -1.06% move from the previous day.
